NTI Recorded Session NTI25230

Short Circuit: When the Brain's Electrical System Is in Chaos

Author(s): Mary Kay Bader, MSN, RN, CCNS, CCRN, CNRN, SCRN, FAHA, FNCS

Contact Hours 1.00

CERP A 1.00

Pharmacology Hours 0.20

Expires Dec 31, 2027

Topics: Neurology, Pharmacology

Population: Adult

Role: APRN

Start Activity
Fees
Member: Free
NonMember: $10.00
Get CE

Added to Collection

Activity Summary

Patients with convulsive status epilepticus (CSE) are easy to identify. Those in nonconvulsive status epilepticus (NCSE) often present with altered mental status/subtle signs. This presentation focuses on quickly identifying SE, intervening with appropriate interventions and medications to stop the seizures and developing hospital protocols with EEG monitoring to confirm/manage SE. Pharmacology content = 20%

Objectives

  • Distinguish between CSE and NCSE.
  • Categorize medications into first-tier, second-tier and third-tier interventions to manage SE using case studies.
  • Develop hospital-based protocols on managing CSE/NCSE, ensuring advanced monitoring/care.

Continuing Education Disclosure Statement

Criteria for Awarding Contact Hours

Learners must complete the entire activity and the associated evaluation AND read Implicit Bias impacts patient outcomes. No partial credit will be awarded.

Accreditation

American Association of Critical-Care Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Provider approved by the California Board of Registered Nursing, Provider number CEP 1036, for {contactHours} contact hours.

Disclosures

The Nurse Planner has determined that no individuals with the ability to control content of this activity have relevant relationships with ineligible companies.

Activities with pharmacotherapeutic credit are to assist the APRN in fulfilling their education requirements for licensure and certification renewals.

Refund Policy

Continuing Education Activities are nonrefundable.